Also trades as: SAN.PA (PAR) · $vol 175M · SNYNF (OTC) · $vol 2M · SNW.DE (XETRA) · $vol 1M · SNY.TO (TSX) · $vol 0M
SNY NASDAQ
Sanofi
1W: +1.2%
1M: +1.7%
3M: -6.6%
YTD: -13.2%
1Y: -18.9%
3Y: -14.5%
5Y: -2.2%
$41.89
+0.10 (+0.24%)
Weekly Expected Move ±3.8%
$38
$40
$42
$43
$45
Credit Risk of going bust: lower than 81% of companies Debt: 20.7% of company value Bonds: $378.9M held by 102 funds, 19 bp over Treasuries → details ▾
If the stock fell to about $0.67 (down 98%), Sanofi would be worth roughly what it owes.
Total debt $26.24B against a stock market value of $100.37B.
Distance to default 10.01 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $15.97B (short-term plus half of long-term), stock volatility 23.1%; Altman Z'' 1.66. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Total debt $26.24B against a stock market value of $100.37B.
Distance to default 10.01 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $15.97B (short-term plus half of long-term), stock volatility 23.1%; Altman Z'' 1.66. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$49B
Revenue
+13.4% YoY
$4B
Net Income
-56.6% YoY
$12B
Free Cash Flow
+63.6% YoY
75.5%
Gross Margin
19.4%
Op. Margin
2.8%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE5.7%
ROA3.1%
ROIC6.4%
Valuation
P/E23.0
P/B1.3
EV/EBITDA0.0
Leverage
Debt/Equity0.34
Current Ratio0.99
Interest Cov.15.0x
Quality Scores
Piotroski F6/9
Altman Z—
Beneish M-2.70